[Research advancement of endogenous angiogenesis inhibitors]

Jiang-Xue Wu1, Ben-Ling Xu, Wen-Lin Huang

  • 1Research Department, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P.R.China.

Insights

Endogenous angiogenesis inhibitors, naturally occurring compounds, show promise in blocking tumor growth and spread. This review explores their potential as novel anti-cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Context:

  • Angiogenesis, the formation of new blood vessels, is crucial for invasive tumor growth and metastasis.
  • Inhibiting angiogenesis is a key strategy in developing effective anti-cancer therapies.
  • Numerous endogenous angiogenesis inhibitors have been identified, with some progressing through clinical trials.

Purpose:

  • To review the structure, function, and mechanisms of endogenous angiogenesis inhibitors.
  • To evaluate the therapeutic potential of these inhibitors in cancer treatment.

Summary:

  • This review details the characteristics of naturally occurring molecules that inhibit angiogenesis.
  • It examines how these inhibitors work at a molecular level and their biological roles.
  • The focus is on their application in combating tumor development and metastasis.

Impact:

  • Highlights the potential of endogenous angiogenesis inhibitors as a new class of anti-cancer drugs.
  • Provides insights into the development of targeted therapies for various cancers.
  • Emphasizes the importance of understanding these inhibitors for future cancer treatment strategies.